fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
fincash number+91-22-48913909
Top 10 Equity Mutual Funds of 2024 | Performance Review

Fincash » Mutual Funds » Best Performing Equity Funds 2018

Best Equity Mutual Funds of 2024

Updated on February 19, 2025 , 648 views

Equity Funds are the ones whose accumulated fund money is invested in equity and equity-related instruments of various companies. The equity funds are considered as a long-term investment option for people having a moderate and high-risk appetite. The various categories of equity funds include Large cap funds, mid cap funds, Small cap funds, ELSS, and so on. In the year 2024, there was an upsurge witnessed in the equity markets due to which most of the equity fund categories have performed well. The performance of these funds depends on a lot of macro and microeconomic parameters such as Industry performance, company performance, the earning and profits of the companies, its future potentials, and so on. The top and Best equity funds for the year 2024 are as follows.

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Top 10 Equity Mutual Funds of 2024 Based on Performance

FundNAVNet Assets (Cr)2023 (%)2022 (%)2021 (%)2020 (%)2019 (%)
Motilal Oswal Midcap 30 Fund  Growth ₹92.0867
↓ -1.17
₹24,48857.141.710.755.89.3
LIC MF Infrastructure Fund Growth ₹41.5144
↑ 0.04
₹88147.844.47.946.6-0.1
Motilal Oswal Long Term Equity Fund Growth ₹43.9487
↓ -0.33
₹3,87647.7371.832.18.8
Motilal Oswal Multicap 35 Fund Growth ₹54.876
↓ -0.51
₹11,85545.731-315.310.3
Invesco India Mid Cap Fund Growth ₹147.65
↓ -2.05
₹5,64543.134.10.543.124.4
UTI Healthcare Fund Growth ₹257.918
↓ -2.52
₹1,15042.938.2-12.319.167.4
SBI Healthcare Opportunities Fund Growth ₹396.896
↑ 1.55
₹3,52242.238.2-620.165.8
TATA India Pharma & Healthcare Fund Growth ₹27.5462
↓ -0.43
₹1,21240.436.6-819.164.4
IDBI Small Cap Fund Growth ₹27.4664
↓ -0.22
₹4914033.42.464.719
L&T Midcap Fund Growth ₹329.402
↓ -4.03
₹10,75339.7401.130.419
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 21 Feb 25

Top & Best Equity Mutual Funds of 2024

1. Motilal Oswal Midcap 30 Fund 

(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Motilal Oswal Midcap 30 Fund  is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 22.4% since its launch.  Ranked 27 in Mid Cap category.  Return for 2024 was 57.1% , 2023 was 41.7% and 2022 was 10.7% .

Below is the key information for Motilal Oswal Midcap 30 Fund 

Motilal Oswal Midcap 30 Fund 
Growth
Launch Date 24 Feb 14
NAV (21 Feb 25) ₹92.0867 ↓ -1.17   (-1.25 %)
Net Assets (Cr) ₹24,488 on 31 Jan 25
Category Equity - Mid Cap
AMC Motilal Oswal Asset Management Co. Ltd
Rating
Risk Moderately High
Expense Ratio 0.66
Sharpe Ratio 0.93
Information Ratio 0.68
Alpha Ratio 15.2
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Jan 20₹10,000
31 Jan 21₹10,284
31 Jan 22₹16,054
31 Jan 23₹17,654
31 Jan 24₹26,102
31 Jan 25₹33,874

Motilal Oswal Midcap 30 Fund  SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹570,326.
Net Profit of ₹270,326
Invest Now

Returns for Motilal Oswal Midcap 30 Fund 

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 21 Feb 25

DurationReturns
1 Month -5.2%
3 Month -11.5%
6 Month -8.1%
1 Year 21.1%
3 Year 27.9%
5 Year 26%
10 Year
15 Year
Since launch 22.4%
Historical performance (Yearly) on absolute basis
YearReturns
2023 57.1%
2022 41.7%
2021 10.7%
2020 55.8%
2019 9.3%
2018 9.7%
2017 -12.7%
2016 30.8%
2015 5.2%
2014 16.5%
Fund Manager information for Motilal Oswal Midcap 30 Fund 
NameSinceTenure
Ajay Khandelwal1 Oct 240.34 Yr.
Niket Shah1 Jul 204.59 Yr.
Rakesh Shetty22 Nov 222.2 Yr.
Sunil Sawant1 Jul 240.59 Yr.

Data below for Motilal Oswal Midcap 30 Fund  as on 31 Jan 25

Equity Sector Allocation
SectorValue
Technology29.21%
Consumer Cyclical25.34%
Industrials19.64%
Financial Services5.14%
Health Care4.07%
Communication Services2.9%
Utility2.05%
Real Estate1.98%
Basic Materials0.47%
Asset Allocation
Asset ClassValue
Cash9.2%
Equity90.8%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE
10%₹2,604 Cr2,695,000
↑ 95,000
Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL
10%₹2,548 Cr33,250,000
↑ 2,750,000
Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB
9%₹2,364 Cr3,250,000
↑ 124,982
Trent Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | 500251
8%₹2,137 Cr3,000,000
↑ 1,250,400
Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT
8%₹2,099 Cr3,250,000
↑ 250,000
Jio Financial Services Ltd (Financial Services)
Equity, Since 31 Aug 23 | JIOFIN
5%₹1,359 Cr45,500,000
↑ 3,000,000
Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 Oct 24 | M&M
4%₹1,052 Cr3,500,000
↓ -1,250,000
Oracle Financial Services Software Ltd (Technology)
Equity, Since 31 Dec 24 | OFSS
4%₹1,019 Cr796,967
↑ 796,967
One97 Communications Ltd (Technology)
Equity, Since 30 Sep 24 | 543396
4%₹1,018 Cr10,000,000
↑ 2,500,000
Voltas Ltd (Industrials)
Equity, Since 31 Oct 17 | VOLTAS
3%₹895 Cr4,999,745

2. LIC MF Infrastructure Fund

The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector.

LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a CAGR/Annualized return of 8.7% since its launch.  Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% .

Below is the key information for LIC MF Infrastructure Fund

LIC MF Infrastructure Fund
Growth
Launch Date 29 Feb 08
NAV (21 Feb 25) ₹41.5144 ↑ 0.04   (0.11 %)
Net Assets (Cr) ₹881 on 31 Jan 25
Category Equity - Sectoral
AMC LIC Mutual Fund Asset Mgmt Co Ltd
Rating Not Rated
Risk High
Expense Ratio 2.3
Sharpe Ratio 0.83
Information Ratio 0.66
Alpha Ratio 16.19
Min Investment 5,000
Min SIP Investment 1,000
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Jan 20₹10,000
31 Jan 21₹9,834
31 Jan 22₹14,762
31 Jan 23₹15,309
31 Jan 24₹24,273
31 Jan 25₹30,162

LIC MF Infrastructure Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹530,691.
Net Profit of ₹230,691
Invest Now

Returns for LIC MF Infrastructure Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 21 Feb 25

DurationReturns
1 Month -12.8%
3 Month -14.7%
6 Month -19.9%
1 Year 12.7%
3 Year 24.1%
5 Year 22.3%
10 Year
15 Year
Since launch 8.7%
Historical performance (Yearly) on absolute basis
YearReturns
2023 47.8%
2022 44.4%
2021 7.9%
2020 46.6%
2019 -0.1%
2018 13.3%
2017 -14.6%
2016 42.2%
2015 -2.2%
2014 -6.2%
Fund Manager information for LIC MF Infrastructure Fund
NameSinceTenure
Yogesh Patil18 Sep 204.38 Yr.
Mahesh Bendre1 Jul 240.59 Yr.

Data below for LIC MF Infrastructure Fund as on 31 Jan 25

Equity Sector Allocation
SectorValue
Industrials50.6%
Basic Materials11.02%
Consumer Cyclical9.84%
Utility7.43%
Financial Services6.38%
Technology3.93%
Real Estate1.91%
Communication Services1.88%
Energy1.29%
Health Care0.2%
Asset Allocation
Asset ClassValue
Cash5.52%
Equity94.48%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 500655
5%₹43 Cr86,410
Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP
5%₹42 Cr391,152
REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 532955
3%₹26 Cr525,720
Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER
3%₹25 Cr328,026
GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 522275
3%₹25 Cr120,063
Bharat Bijlee Ltd (Industrials)
Equity, Since 31 Jul 22 | BBL
2%₹22 Cr59,231
↑ 7,625
Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 500400
2%₹22 Cr554,470
↑ 80,934
Cummins India Ltd (Industrials)
Equity, Since 31 May 21 | 500480
2%₹22 Cr66,145
ISGEC Heavy Engineering Ltd (Industrials)
Equity, Since 31 Jul 24 | 533033
2%₹22 Cr149,711
Bharat Forge Ltd (Consumer Cyclical)
Equity, Since 30 Sep 21 | 500493
2%₹21 Cr158,209
↑ 48,733

3. Motilal Oswal Long Term Equity Fund

(Erstwhile Motilal Oswal MOSt Focused Long Term Fund)

The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Motilal Oswal Long Term Equity Fund is a Equity - ELSS fund was launched on 21 Jan 15. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 15.8% since its launch.  Return for 2024 was 47.7% , 2023 was 37% and 2022 was 1.8% .

Below is the key information for Motilal Oswal Long Term Equity Fund

Motilal Oswal Long Term Equity Fund
Growth
Launch Date 21 Jan 15
NAV (21 Feb 25) ₹43.9487 ↓ -0.33   (-0.75 %)
Net Assets (Cr) ₹3,876 on 31 Jan 25
Category Equity - ELSS
AMC Motilal Oswal Asset Management Co. Ltd
Rating Not Rated
Risk Moderately High
Expense Ratio 0.74
Sharpe Ratio 0.74
Information Ratio 0.72
Alpha Ratio 10.73
Min Investment 500
Min SIP Investment 500
Exit Load NIL

Growth of 10,000 investment over the years.

DateValue
31 Jan 20₹10,000
31 Jan 21₹10,501
31 Jan 22₹13,929
31 Jan 23₹13,836
31 Jan 24₹20,216
31 Jan 25₹24,623

Motilal Oswal Long Term Equity Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹470,047.
Net Profit of ₹170,047
Invest Now

Returns for Motilal Oswal Long Term Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 21 Feb 25

DurationReturns
1 Month -10.8%
3 Month -14.6%
6 Month -14.1%
1 Year 9.2%
3 Year 19.3%
5 Year 17.6%
10 Year
15 Year
Since launch 15.8%
Historical performance (Yearly) on absolute basis
YearReturns
2023 47.7%
2022 37%
2021 1.8%
2020 32.1%
2019 8.8%
2018 13.2%
2017 -8.7%
2016 44%
2015 12.5%
2014
Fund Manager information for Motilal Oswal Long Term Equity Fund
NameSinceTenure
Ajay Khandelwal11 Dec 231.15 Yr.
Rakesh Shetty22 Nov 222.2 Yr.
Atul Mehra1 Oct 240.34 Yr.

Data below for Motilal Oswal Long Term Equity Fund as on 31 Jan 25

Equity Sector Allocation
SectorValue
Industrials32.1%
Consumer Cyclical24.6%
Financial Services16.39%
Technology10.16%
Real Estate6.74%
Basic Materials6.02%
Health Care2.93%
Asset Allocation
Asset ClassValue
Cash1.05%
Equity98.95%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Trent Ltd (Consumer Cyclical)
Equity, Since 31 Aug 22 | 500251
7%₹303 Cr425,260
Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 543320
6%₹276 Cr9,923,692
Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | KALYANKJIL
5%₹240 Cr3,134,622
Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 23 | KAYNES
5%₹221 Cr297,751
Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Oct 23 | PRESTIGE
4%₹179 Cr1,055,205
Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Mar 24 | AMBER
4%₹174 Cr235,044
Premier Energies Ltd (Technology)
Equity, Since 30 Sep 24 | PREMIERENE
4%₹172 Cr1,267,798
Gujarat Fluorochemicals Ltd Ordinary Shares (Basic Materials)
Equity, Since 28 Feb 23 | FLUOROCHEM
4%₹170 Cr408,886
Coforge Ltd (Technology)
Equity, Since 31 Jul 24 | COFORGE
4%₹163 Cr168,355
Apar Industries Ltd (Industrials)
Equity, Since 31 Dec 23 | APARINDS
3%₹153 Cr148,305

4. Motilal Oswal Multicap 35 Fund

(Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Motilal Oswal Multicap 35 Fund is a Equity - Multi Cap fund was launched on 28 Apr 14. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 17% since its launch.  Ranked 5 in Multi Cap category.  Return for 2024 was 45.7% , 2023 was 31% and 2022 was -3% .

Below is the key information for Motilal Oswal Multicap 35 Fund

Motilal Oswal Multicap 35 Fund
Growth
Launch Date 28 Apr 14
NAV (21 Feb 25) ₹54.876 ↓ -0.51   (-0.92 %)
Net Assets (Cr) ₹11,855 on 31 Jan 25
Category Equity - Multi Cap
AMC Motilal Oswal Asset Management Co. Ltd
Rating
Risk Moderately High
Expense Ratio 0.94
Sharpe Ratio 0.9
Information Ratio 0.49
Alpha Ratio 13.01
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Jan 20₹10,000
31 Jan 21₹10,769
31 Jan 22₹12,393
31 Jan 23₹11,662
31 Jan 24₹16,589
31 Jan 25₹20,775

Motilal Oswal Multicap 35 Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹436,710.
Net Profit of ₹136,710
Invest Now

Returns for Motilal Oswal Multicap 35 Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 21 Feb 25

DurationReturns
1 Month -3.4%
3 Month -7.4%
6 Month -4.7%
1 Year 18.5%
3 Year 18.9%
5 Year 14.6%
10 Year
15 Year
Since launch 17%
Historical performance (Yearly) on absolute basis
YearReturns
2023 45.7%
2022 31%
2021 -3%
2020 15.3%
2019 10.3%
2018 7.9%
2017 -7.8%
2016 43.1%
2015 8.5%
2014 14.6%
Fund Manager information for Motilal Oswal Multicap 35 Fund
NameSinceTenure
Ajay Khandelwal1 Oct 240.34 Yr.
Niket Shah1 Jul 222.59 Yr.
Santosh Singh1 Aug 231.51 Yr.
Rakesh Shetty22 Nov 222.2 Yr.
Atul Mehra1 Oct 240.34 Yr.
Sunil Sawant1 Jul 240.59 Yr.

Data below for Motilal Oswal Multicap 35 Fund as on 31 Jan 25

Equity Sector Allocation
SectorValue
Consumer Cyclical29.39%
Technology24.11%
Industrials15.4%
Financial Services13.86%
Communication Services8.09%
Health Care1.71%
Asset Allocation
Asset ClassValue
Cash7.42%
Equity92.58%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Coforge Ltd (Technology)
Equity, Since 31 May 23 | COFORGE
11%₹1,391 Cr1,440,000
↑ 10,000
Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 30 Sep 23 | KALYANKJIL
10%₹1,322 Cr17,250,000
Polycab India Ltd (Industrials)
Equity, Since 31 Jan 24 | POLYCAB
10%₹1,309 Cr1,800,000
Trent Ltd (Consumer Cyclical)
Equity, Since 31 Jan 23 | 500251
10%₹1,300 Cr1,825,000
↑ 21,084
Persistent Systems Ltd (Technology)
Equity, Since 31 Mar 23 | PERSISTENT
10%₹1,292 Cr2,000,000
Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 Oct 24 | M&M
7%₹977 Cr3,250,000
↓ -200,000
Jio Financial Services Ltd (Financial Services)
Equity, Since 31 Jul 23 | JIOFIN
7%₹971 Cr32,500,000
Bharti Airtel Ltd (Partly Paid Rs.1.25) (Communication Services)
Equity, Since 30 Apr 24 | 890157
4%₹589 Cr5,000,000
Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 31 Mar 23 | CHOLAFIN
4%₹534 Cr4,500,000
PG Electroplast Ltd (Technology)
Equity, Since 31 Dec 24 | PGEL
4%₹490 Cr5,000,000
↑ 5,000,000

5. Invesco India Mid Cap Fund

The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved.

Invesco India Mid Cap Fund is a Equity - Mid Cap fund was launched on 19 Apr 07. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 16.3% since its launch.  Ranked 38 in Mid Cap category.  Return for 2024 was 43.1% , 2023 was 34.1% and 2022 was 0.5% .

Below is the key information for Invesco India Mid Cap Fund

Invesco India Mid Cap Fund
Growth
Launch Date 19 Apr 07
NAV (21 Feb 25) ₹147.65 ↓ -2.05   (-1.37 %)
Net Assets (Cr) ₹5,645 on 31 Jan 25
Category Equity - Mid Cap
AMC Invesco Asset Management (India) Private Ltd
Rating
Risk Moderately High
Expense Ratio 1.89
Sharpe Ratio 0.82
Information Ratio 0
Alpha Ratio 0
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Jan 20₹10,000
31 Jan 21₹11,867
31 Jan 22₹16,557
31 Jan 23₹16,505
31 Jan 24₹23,754
31 Jan 25₹29,165

Invesco India Mid Cap Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹518,033.
Net Profit of ₹218,033
Invest Now

Returns for Invesco India Mid Cap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 21 Feb 25

DurationReturns
1 Month -6.3%
3 Month -8.4%
6 Month -7.6%
1 Year 15.2%
3 Year 21.1%
5 Year 21.7%
10 Year
15 Year
Since launch 16.3%
Historical performance (Yearly) on absolute basis
YearReturns
2023 43.1%
2022 34.1%
2021 0.5%
2020 43.1%
2019 24.4%
2018 3.8%
2017 -5.3%
2016 44.3%
2015 1.1%
2014 6.4%
Fund Manager information for Invesco India Mid Cap Fund
NameSinceTenure
Aditya Khemani9 Nov 231.23 Yr.
Amit Ganatra1 Sep 231.42 Yr.

Data below for Invesco India Mid Cap Fund as on 31 Jan 25

Equity Sector Allocation
SectorValue
Consumer Cyclical25.51%
Financial Services17.04%
Health Care15.23%
Industrials12.25%
Technology11.48%
Real Estate7.31%
Basic Materials7.02%
Communication Services1.3%
Asset Allocation
Asset ClassValue
Cash2.85%
Equity97.15%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Dixon Technologies (India) Ltd (Technology)
Equity, Since 28 Feb 22 | DIXON
5%₹279 Cr155,335
Trent Ltd (Consumer Cyclical)
Equity, Since 30 Apr 21 | 500251
4%₹259 Cr363,079
↑ 28,336
Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | MAXHEALTH
4%₹253 Cr2,246,434
The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK
4%₹250 Cr12,506,782
BSE Ltd (Financial Services)
Equity, Since 31 Dec 23 | BSE
4%₹232 Cr436,534
Coforge Ltd (Technology)
Equity, Since 31 Mar 22 | COFORGE
4%₹227 Cr234,918
Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE
4%₹221 Cr1,305,659
L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF
3%₹182 Cr13,455,088
JK Cement Ltd (Basic Materials)
Equity, Since 31 Oct 22 | JKCEMENT
3%₹173 Cr376,558
InterGlobe Aviation Ltd (Industrials)
Equity, Since 30 Apr 24 | INDIGO
3%₹157 Cr344,322

6. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a CAGR/Annualized return of 14.8% since its launch.  Ranked 40 in Sectoral category.  Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% .

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund
Growth
Launch Date 28 Jun 99
NAV (21 Feb 25) ₹257.918 ↓ -2.52   (-0.97 %)
Net Assets (Cr) ₹1,150 on 31 Jan 25
Category Equity - Sectoral
AMC UTI Asset Management Company Ltd
Rating
Risk High
Expense Ratio 2.38
Sharpe Ratio 1.03
Information Ratio -0.36
Alpha Ratio 0.34
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Jan 20₹10,000
31 Jan 21₹15,455
31 Jan 22₹17,925
31 Jan 23₹16,531
31 Jan 24₹24,618
31 Jan 25₹30,793

UTI Healthcare Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹530,691.
Net Profit of ₹230,691
Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 21 Feb 25

DurationReturns
1 Month -7.2%
3 Month -7.5%
6 Month -5.7%
1 Year 13.9%
3 Year 19.5%
5 Year 23%
10 Year
15 Year
Since launch 14.8%
Historical performance (Yearly) on absolute basis
YearReturns
2023 42.9%
2022 38.2%
2021 -12.3%
2020 19.1%
2019 67.4%
2018 1.2%
2017 -7.5%
2016 6.2%
2015 -9.7%
2014 12.4%
Fund Manager information for UTI Healthcare Fund
NameSinceTenure
Kamal Gada2 May 222.76 Yr.

Data below for UTI Healthcare Fund as on 31 Jan 25

Equity Sector Allocation
SectorValue
Health Care96.03%
Basic Materials1.27%
Financial Services0.29%
Asset Allocation
Asset ClassValue
Cash2.41%
Equity97.59%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
11%₹137 Cr725,000
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087
6%₹71 Cr464,949
↑ 14,289
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY
5%₹65 Cr470,234
Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 532331
5%₹57 Cr193,047
Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 532296
4%₹50 Cr309,311
Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND
4%₹47 Cr266,306
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP
4%₹44 Cr60,000
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 532843
3%₹40 Cr557,701
↓ -53,957
Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL
3%₹39 Cr74,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
3%₹37 Cr61,480

7. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a CAGR/Annualized return of 15.4% since its launch.  Ranked 34 in Sectoral category.  Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% .

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund
Growth
Launch Date 31 Dec 04
NAV (20 Feb 25) ₹396.896 ↑ 1.55   (0.39 %)
Net Assets (Cr) ₹3,522 on 31 Jan 25
Category Equity - Sectoral
AMC SBI Funds Management Private Limited
Rating
Risk High
Expense Ratio 2.09
Sharpe Ratio 1.36
Information Ratio 0.67
Alpha Ratio 4.66
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Jan 20₹10,000
31 Jan 21₹15,535
31 Jan 22₹17,594
31 Jan 23₹17,709
31 Jan 24₹26,160
31 Jan 25₹33,176

SBI Healthcare Opportunities Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹556,833.
Net Profit of ₹256,833
Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 21 Feb 25

DurationReturns
1 Month -5.5%
3 Month -3.7%
6 Month 0.5%
1 Year 14.2%
3 Year 22.5%
5 Year 24.4%
10 Year
15 Year
Since launch 15.4%
Historical performance (Yearly) on absolute basis
YearReturns
2023 42.2%
2022 38.2%
2021 -6%
2020 20.1%
2019 65.8%
2018 -0.5%
2017 -9.9%
2016 2.1%
2015 -14%
2014 27.1%
Fund Manager information for SBI Healthcare Opportunities Fund
NameSinceTenure
Tanmaya Desai1 Jun 1113.68 Yr.
Pradeep Kesavan31 Dec 231.09 Yr.

Data below for SBI Healthcare Opportunities Fund as on 31 Jan 25

Equity Sector Allocation
SectorValue
Health Care90.04%
Basic Materials6.53%
Asset Allocation
Asset ClassValue
Cash3.35%
Equity96.57%
Debt0.08%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA
13%₹472 Cr2,500,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH
6%₹226 Cr2,000,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB
6%₹220 Cr360,000
Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 500087
6%₹214 Cr1,400,000
↑ 120,000
Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 500257
5%₹188 Cr800,000
Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY
4%₹151 Cr300,000
Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND
4%₹151 Cr523,016
↑ 123,016
Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED
4%₹131 Cr500,000
Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 543308
3%₹126 Cr2,100,000
↓ -100,000
Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL
3%₹125 Cr800,000
↓ -32,871

8. TATA India Pharma & Healthcare Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a CAGR/Annualized return of 11.7% since its launch.  Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% .

Below is the key information for TATA India Pharma & Healthcare Fund

TATA India Pharma & Healthcare Fund
Growth
Launch Date 28 Dec 15
NAV (21 Feb 25) ₹27.5462 ↓ -0.43   (-1.52 %)
Net Assets (Cr) ₹1,212 on 31 Jan 25
Category Equity - Sectoral
AMC Tata Asset Management Limited
Rating Not Rated
Risk High
Expense Ratio 0
Sharpe Ratio 0.9
Information Ratio 0.56
Alpha Ratio 2.72
Min Investment 5,000
Min SIP Investment 150
Exit Load 0-3 Months (0.25%),3 Months and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Jan 20₹10,000
31 Jan 21₹15,073
31 Jan 22₹17,565
31 Jan 23₹16,932
31 Jan 24₹24,972
31 Jan 25₹30,507

TATA India Pharma & Healthcare Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹530,691.
Net Profit of ₹230,691
Invest Now

Returns for TATA India Pharma & Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 21 Feb 25

DurationReturns
1 Month -7.8%
3 Month -6.6%
6 Month -8.7%
1 Year 8.9%
3 Year 19%
5 Year 22.1%
10 Year
15 Year
Since launch 11.7%
Historical performance (Yearly) on absolute basis
YearReturns
2023 40.4%
2022 36.6%
2021 -8%
2020 19.1%
2019 64.4%
2018 5.5%
2017 -2.6%
2016 4.7%
2015 -14.7%
2014
Fund Manager information for TATA India Pharma & Healthcare Fund
NameSinceTenure
Meeta Shetty9 Mar 213.9 Yr.
Rajat Srivastava16 Sep 240.38 Yr.

Data below for TATA India Pharma & Healthcare Fund as on 31 Jan 25

Equity Sector Allocation
SectorValue
Health Care92.85%
Basic Materials2.06%
Asset Allocation
Asset ClassValue
Cash5.1%
Equity94.9%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA
12%₹152 Cr804,300
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA
8%₹99 Cr741,000
Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 500257
8%₹97 Cr410,240
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY
7%₹85 Cr614,555
Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 500087
6%₹75 Cr490,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
5%₹64 Cr104,965
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 532843
5%₹62 Cr855,100
Zydus Lifesciences Ltd (Healthcare)
Equity, Since 31 Dec 22 | 532321
4%₹46 Cr471,287
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP
3%₹43 Cr58,903
Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM
3%₹42 Cr75,249

9. IDBI Small Cap Fund

The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However there can be no assurance that the investment objective under the Scheme will be realized.

IDBI Small Cap Fund is a Equity - Small Cap fund was launched on 21 Jun 17. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 14.1% since its launch.  Return for 2024 was 40% , 2023 was 33.4% and 2022 was 2.4% .

Below is the key information for IDBI Small Cap Fund

IDBI Small Cap Fund
Growth
Launch Date 21 Jun 17
NAV (21 Feb 25) ₹27.4664 ↓ -0.22   (-0.80 %)
Net Assets (Cr) ₹491 on 31 Jan 25
Category Equity - Small Cap
AMC IDBI Asset Management Limited
Rating Not Rated
Risk Moderately High
Expense Ratio 2.3
Sharpe Ratio 0.61
Information Ratio 0.24
Alpha Ratio 11.34
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Jan 20₹10,000
31 Jan 21₹11,198
31 Jan 22₹18,406
31 Jan 23₹18,625
31 Jan 24₹26,813
31 Jan 25₹31,771

IDBI Small Cap Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹543,623.
Net Profit of ₹243,623
Invest Now

Returns for IDBI Small Cap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 21 Feb 25

DurationReturns
1 Month -14.2%
3 Month -13.4%
6 Month -16.9%
1 Year 6.3%
3 Year 17.7%
5 Year 23.5%
10 Year
15 Year
Since launch 14.1%
Historical performance (Yearly) on absolute basis
YearReturns
2023 40%
2022 33.4%
2021 2.4%
2020 64.7%
2019 19%
2018 -4.4%
2017 -15%
2016
2015
2014
Fund Manager information for IDBI Small Cap Fund
NameSinceTenure
Nikhil Rungta1 Jul 240.59 Yr.
Mahesh Bendre1 Jul 240.59 Yr.

Data below for IDBI Small Cap Fund as on 31 Jan 25

Equity Sector Allocation
SectorValue
Industrials34.87%
Consumer Cyclical15.44%
Basic Materials14.33%
Utility7.2%
Consumer Defensive6.79%
Health Care5.43%
Financial Services4.84%
Technology4.29%
Communication Services2.98%
Real Estate1.44%
Asset Allocation
Asset ClassValue
Cash2.39%
Equity97.61%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
International Gemmological Institute (India) Ltd (Basic Materials)
Equity, Since 31 Dec 24 | 544311
4%₹16 Cr294,700
↑ 294,700
JTL Industries Ltd (Basic Materials)
Equity, Since 31 Jul 24 | 534600
3%₹14 Cr1,422,834
↑ 159,260
Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP
3%₹13 Cr124,085
↓ -18,745
Allied Blenders and Distillers Ltd (Consumer Defensive)
Equity, Since 31 Jul 24 | ABDL
2%₹10 Cr244,147
Kilburn Engineering Ltd (Industrials)
Equity, Since 30 Nov 24 | 522101
2%₹10 Cr215,000
Himatsingka Seide Ltd (Consumer Cyclical)
Equity, Since 31 Oct 24 | 514043
2%₹10 Cr545,700
TD Power Systems Ltd (Industrials)
Equity, Since 31 Aug 23 | TDPOWERSYS
2%₹10 Cr224,441
Navkar Corp Ltd (Industrials)
Equity, Since 31 Jul 24 | NAVKARCORP
2%₹10 Cr588,318
Tata Power Co Ltd (Utilities)
Equity, Since 30 Sep 24 | 500400
2%₹10 Cr246,957
↑ 43,734
Artemis Medicare Services Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Oct 23 | 542919
2%₹9 Cr296,517

10. L&T Midcap Fund

To generate capital appreciation by investing primarily in midcap stocks. The scheme will invest primarily in companies whose market capitalization falls between the highest and the lowest constituent of the Nifty Free Float Midcap 100.

L&T Midcap Fund is a Equity - Mid Cap fund was launched on 9 Aug 04. It is a fund with High risk and has given a CAGR/Annualized return of 18.6% since its launch.  Ranked 5 in Mid Cap category.  Return for 2024 was 39.7% , 2023 was 40% and 2022 was 1.1% .

Below is the key information for L&T Midcap Fund

L&T Midcap Fund
Growth
Launch Date 9 Aug 04
NAV (21 Feb 25) ₹329.402 ↓ -4.03   (-1.21 %)
Net Assets (Cr) ₹10,753 on 31 Jan 25
Category Equity - Mid Cap
AMC L&T Investment Management Ltd
Rating
Risk High
Expense Ratio 1.77
Sharpe Ratio 0.53
Information Ratio -0.14
Alpha Ratio 4.43
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Jan 20₹10,000
31 Jan 21₹11,149
31 Jan 22₹14,583
31 Jan 23₹14,755
31 Jan 24₹21,674
31 Jan 25₹25,267

L&T Midcap Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹481,656.
Net Profit of ₹181,656
Invest Now

Returns for L&T Midcap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 21 Feb 25

DurationReturns
1 Month -8.8%
3 Month -13.2%
6 Month -15.4%
1 Year 5.5%
3 Year 19.1%
5 Year 18.2%
10 Year
15 Year
Since launch 18.6%
Historical performance (Yearly) on absolute basis
YearReturns
2023 39.7%
2022 40%
2021 1.1%
2020 30.4%
2019 19%
2018 -0.2%
2017 -12%
2016 52.3%
2015 9.8%
2014 10.8%
Fund Manager information for L&T Midcap Fund
NameSinceTenure
Venugopal Manghat1 Oct 231.34 Yr.
Cheenu Gupta26 Nov 222.19 Yr.
Sonal Gupta1 Oct 231.34 Yr.

Data below for L&T Midcap Fund as on 31 Jan 25

Equity Sector Allocation
SectorValue
Industrials29.39%
Financial Services18.39%
Consumer Cyclical14.24%
Technology13.48%
Real Estate7.01%
Health Care6.91%
Utility4.74%
Consumer Defensive2.27%
Basic Materials1.85%
Communication Services0.05%
Asset Allocation
Asset ClassValue
Cash1.66%
Equity98.34%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 May 24 | 500093
5%₹620 Cr8,521,430
↑ 977,930
PB Fintech Ltd (Financial Services)
Equity, Since 31 Jan 24 | 543390
5%₹573 Cr2,719,200
↑ 367,500
Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Apr 24 | DIXON
4%₹547 Cr304,800
Trent Ltd (Consumer Cyclical)
Equity, Since 30 Jun 19 | 500251
4%₹452 Cr634,900
Suzlon Energy Ltd (Industrials)
Equity, Since 31 Mar 24 | SUZLON
4%₹438 Cr70,452,868
↓ -19,954,232
Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Mar 24 | 543320
3%₹421 Cr15,135,559
HDFC Asset Management Co Ltd (Financial Services)
Equity, Since 31 Dec 22 | HDFCAMC
3%₹405 Cr964,400
JSW Energy Ltd (Utilities)
Equity, Since 31 Mar 24 | JSWENERGY
3%₹404 Cr6,288,700
BSE Ltd (Financial Services)
Equity, Since 30 Apr 24 | BSE
3%₹398 Cr747,800
↑ 59,750
Godrej Properties Ltd (Real Estate)
Equity, Since 31 Mar 17 | GODREJPROP
3%₹378 Cr1,357,604
↑ 182,504

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
How helpful was this page ?
POST A COMMENT